1. Home
  2. EIG vs IOVA Comparison

EIG vs IOVA Comparison

Compare EIG & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • IOVA
  • Stock Information
  • Founded
  • EIG 2000
  • IOVA 2007
  • Country
  • EIG United States
  • IOVA United States
  • Employees
  • EIG N/A
  • IOVA N/A
  • Industry
  • EIG Property-Casualty Insurers
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EIG Finance
  • IOVA Health Care
  • Exchange
  • EIG Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • EIG 1.2B
  • IOVA 1.0B
  • IPO Year
  • EIG 2007
  • IOVA N/A
  • Fundamental
  • Price
  • EIG $49.59
  • IOVA $1.75
  • Analyst Decision
  • EIG Strong Buy
  • IOVA Strong Buy
  • Analyst Count
  • EIG 1
  • IOVA 9
  • Target Price
  • EIG $58.00
  • IOVA $15.50
  • AVG Volume (30 Days)
  • EIG 157.8K
  • IOVA 13.9M
  • Earning Date
  • EIG 05-01-2025
  • IOVA 05-08-2025
  • Dividend Yield
  • EIG 2.58%
  • IOVA N/A
  • EPS Growth
  • EIG N/A
  • IOVA N/A
  • EPS
  • EIG 4.13
  • IOVA N/A
  • Revenue
  • EIG $860,200,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • EIG $1.01
  • IOVA $182.20
  • Revenue Next Year
  • EIG $2.80
  • IOVA $62.10
  • P/E Ratio
  • EIG $12.00
  • IOVA N/A
  • Revenue Growth
  • EIG N/A
  • IOVA 11070.12
  • 52 Week Low
  • EIG $40.57
  • IOVA $2.70
  • 52 Week High
  • EIG $54.44
  • IOVA $13.60
  • Technical
  • Relative Strength Index (RSI)
  • EIG 55.29
  • IOVA 23.78
  • Support Level
  • EIG $47.80
  • IOVA $3.02
  • Resistance Level
  • EIG $49.98
  • IOVA $3.31
  • Average True Range (ATR)
  • EIG 1.05
  • IOVA 0.24
  • MACD
  • EIG 0.15
  • IOVA -0.09
  • Stochastic Oscillator
  • EIG 85.87
  • IOVA 4.81

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: